Genya Dana | Chief Strategy and Bioeconomic Development Officer
Dr. Genya Dana is BioMADE’s Chief Strategy and Bioeconomic Development Officer. Her expertise centers on working with governments and C-suite leaders to set the strategic direction for new initiatives that drive cutting-edge science and technology into complex systems. Prior to joining BioMADE, she served as Chief Health Strategy Officer at Avellino, a young genomics biotech company in Menlo Park, CA, where she built partnerships that sourced the investment, research assets, and technology partners to enable the company to grow and pivot into new commercial areas. Prior to this C-suite role, she spent five years at the Swiss-based World Economic Forum building multi-stakeholder programs and partnerships to catalyse sustainable and innovative uptake of new technologies, financial models, and treatment options to improve health and well-being globally. She also served as a scientific advisor on emerging technologies to diplomats and foreign policy officials at the U.S. Department of State in Washington, DC, while negotiating agreements on science, technology and innovation in multi-lateral organizations like the United Nations. She has degrees in biology, public policy, and risk assessment, and conducted her PhD research in South Africa.